Adaptive Biotechnologies: Nitin Sood
Adaptive Biotechnologies has appointed Nitin Sood to the newly created position of chief commercial officer. Sood has more than 15 years of experience at life sciences and diagnostics companies, most recently at Guardant Health, where he was senior VP of product development. In his new role he will oversee sales and marketing of Adaptive's immunoSEQ, clonoSEQ, and T-Detect products. Prior to joining Guardant, Sood was CEO of next-generation sequencing sample prep firm NuGEN. He also previously held roles at PerkinElmer and Agilent Technologies.